Germline <i>BRCA2</i> mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy.

Author: Hiroshi HONGO ¹ ; Takeo KOSAKA ¹ ; Hideyuki HAYASHI ² ; Kohei NAKAMURA ² ; Hiroshi NISHIHARA ² ; Shuji MIKAMI ³ ; Himisha BELTRAN ⁴ ; Mototsugu OYA ¹
Author Information

1. Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
2. Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
3. Division of Diagnostic Pathology, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
4. Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Publication Type:Letter
MeSH: BRCA2 Protein/genetics*; Germ Cells; Humans; Male; Muscular Atrophy; Mutation; Prostate; Prostatic Neoplasms/genetics*
From: Asian Journal of Andrology 2022;24(1):116-118
CountryChina
Language:English